Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q1 2026 · 10-Q
Revenue$2.26K$2.26K−98.6% vs Q1 2025 Net Income-$139.66K-$139.66KN/M vs Q1 2025 EPS Diluted$0.00$0.00−100.0% vs Q1 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
Operating Cash Flow-$56,218N/M Margins · derivedGross margin-530.0%−606.1 pt vs Q1 2025
Operating margin-5289.8%−5303.6 pt vs Q1 2025
Net margin-6179.4%−6183.0 pt vs Q1 2025
ended Mar 31, 2026 · filed May 19, 2026 · 49 d after period end